-
艾媒报告|2020年中国后疫时代医疗防护行业及细分领域分析报告
本报告研究涉及企业/品牌/案例:欣龙控股,振德医疗,奥美医疗,尚荣医疗,际华集团,蓝帆医疗,兵装集团;其他提及企业/品牌:金三发科技,中国石油,赢合科技,鑫台铭,斯凯瑞,CM朝美,华东医药,爱马斯,海王星辰,北京同仁堂,拼多多,天猫,京东,上海通用五菱,比亚迪,龙头股份,华纺股份,水星家纺,红豆股份
2020年4月3日,全球知名的新经济产业第三方数据挖掘和分析机构iiMedia Research(艾媒咨询) 发布《2020年中国后疫时代医疗防护行业及细分领域分析报告》。报告根据艾媒数据中心、艾媒咨询商业情报数据库、艾媒商情舆情数据监测系统基础数据,对2020年中国医疗防护行业及其细分领域的口罩、防护服、手套、护目镜等进行分析。此外,报告探讨产业上下游的运营模式,结合对欣龙控股、振德医疗、奥美医疗、尚荣医疗、际华集团、蓝帆医疗和兵装集团等典型企业的案例分析,对钢铁行业总体运行情况进行分析,并结合新冠疫情对2020-2021年中国医疗防护产业发展进行趋势预判。相较于发达国家,中国的医疗防护行业起步晚,防护水平低,由于医疗防护用品属于低值耗材,所以国内市场的品牌化理念也不强。但是,随着近些年中国经济的发展,国内的医疗防护市场逐渐升温,新老企业都有了品牌意识。在未来的发展道路上,品牌化和专业化将成为国内医疗防护用品生产企业的核心竞争力。
The outbreak of new crown pneumonia has raised awareness of personal protection, and the market potential for medical protective supplies is huge, and China's demand for medical protective equipment such as masks and gloves is expected to grow rapidly. In addition, the global outbreak of the new crown has also become a great opportunity for the export of China's medical protection products. As the first region to erupt in the outbreak, China has the first advantage of medical protective supplies, and the production capacity of medical protective supplies can be exported overseas. -
艾媒报告|2020中国独角兽TOP100榜单及标杆企业研究报告
本报告研究涉及企业/品牌/案例:乂学教育-松鼠Ai 1对1,每日优鲜,美菜网,微医,联影医疗,快手,云从科技,滴滴出行,小鹏汽车,菜鸟网络,苏宁金融,柔宇科技,奇安信;其他提及企业/品牌:阿里巴巴,腾讯,京东,蚂蚁金服,京东数科,橙行智动,字节跳动 ,智者天下,度小满,小桔科技,商汤科技,喜马拉雅,地平线,陆金所,云杉世界,搜车网 ,满帮集团,云从科技,深兰科技 ,威马汽车,银联商务,车和家,大疆创新,微医云,小船出海,悦易网络,微众银行,优必选,猿力教育,寒武纪元,比特大陆,柔宇科技,行吟信息,拜腾汽车,小屋信息 ,优客工场,准时达,车好多,自如,智车优行,依图科技,葆扬投资,彬讯科技,钱大妈,一起作业,呯嘭智能,涂鸦科技,奥比中光,洋码头,麒麟合盛,途家在线,密境和风,图森未来,蚂蜂窝,纳恩博,悦畅科技,特斯联,新潮传媒,优行科技,第四范式,碳云智能,同盾科技,一点网聚,云知声,随手科技,八戒网络,数梦工场,首约科技,小马智行,虫极科技,联易融,诺禾致源,魅族,博鳌纵横,找钢网,圆心科技,影谱科技,氪空间,越海全球,花旺在线,快跑信息,丰巢科技,医云科技,淘友天下,华云数据,沪江教育,酒仙网,易动纷享,羽扇智,适赫物流,辣妈帮,贝贝集团,斑马网络,初速度,汇通天下,连尚网络
iiMedia Research(艾媒咨询)数据显示,2020年中国独角兽TOP100企业中,地域方面,北京、上海和深圳分别出现39、20和15家独角兽企业,总占比达74%;行业领域方面,人工智能与电商零售领域的独角兽企业发展较为迅速,上榜企业达33家。受益于新兴技术以及庞大的消费人群,与大众消费相关的独角兽企业发展较快,数量占到46%。艾媒咨询分析师认为,在2020年新冠疫情的影响下,中国宏观经济下行压力加剧,独角兽企业也将面临全新的机遇和挑战,一方面不少独角兽企业将受益于国家新老基建投资以及内需扩容提质等政策刺激快速发展,另一方面在全球经济增速放缓的情况下独角兽企业也将面临更激烈的竞争,生存发展压力加剧。
Among the unicorn TOP100 companies in China in 2020, Beijing, Shanghai and Shenzhen have 39, 20, and 15 unicorn companies accounted for 74% of the total; in the field of industry, unicorn companies in the field of artificial intelligence and e-commerce retail developed rapidly, with 33 companies on the list. Benefiting from emerging technologies and a large consumer population, unicorn companies related to mass consumption have developed rapidly, accounting for 46% of the total. iiMedia Consulting analysts believe that under the influence of the new crown epidemic in 2020, China's macroeconomic downward pressure will increase, and unicorn companies will also face new opportunities and challenges. On the one hand, many unicorn companies will benefit from national infrastructure Policies such as investment and domestic demand expansion and quality spur rapid development. On the other hand, with the global economic growth slowing down, unicorn companies will also face more intense competition and intensify the pressure on survival and development. -
艾媒报告|2019-2022中国医疗器械市场大数据及标杆企业运行监测报告
本报告研究涉及企业/品牌/案例:安健科技,万东医疗,康达国际,上海联影,深圳迈瑞佳能,飞利浦,柯达,西门子,GE,安健,万东,通用电气,安科,东软丹纳赫,罗氏,利德曼,强生,科华,美康,九强,日立,迈克,东芝,中生,雅培,迪瑞,大基康明,金杏,致远,成武,长庚,康健,鑫乐,瑞琦,力因精准,积水,威高,拱东,三力,阳普医疗,BD,奥凯龙,重庆多泰,成都威力生,广州暨华,威海威高,山外山,金宝,尼普洛,百特,贝朗,费森透析,美敦力,鱼疗,理邦,尚荣医疗,英科医疗
相比于全球医疗器械市场,近三年中国医疗器械市场的结构已趋向优化但结构依然严重不平衡。早期中国医疗器械市场中,中低端产品占据了将近70%的比例,而高端产品仅占30%左右的比例,而国际医疗器械市场的结构为高端产品占55%,低端产品占45%。如新华医疗、迪安诊断、乐普医疗、鱼跃医疗等积极开拓高端市场及寻求出海发展。艾媒咨询分析师认为,受人工智能、物联网、5G等技术的影响,高端化、智能化和家庭化是中国医疗器械产业发展最为显著的三大趋势。特别是医疗大数据、高端医疗影像设备、家用医疗器械、智能便携式医疗设备等领域将会备受关注。
Compared with the global medical device market, the structure of China's medical device market has been optimized in the past three years, but the structure is still seriously unbalanced. In the early Chinese medical device market, low-end products accounted for nearly 70% of the proportion, while high-end products accounted for only about 30%, while the international medical device market accounted for 55% of high-end products and 45% of low-end products. Such as Xinhua Medical, Dean Diagnostics, Lepu Medical, Yuyue Medical, etc. actively explore the high-end market and seek to develop. iiMedia Research analysts believe that high-end, intelligent and family-oriented are the three most significant trends in the development of China's medical device industry due to the impact of artificial intelligence, Internet of Things, 5G and other technologies. In particular, medical big data, high-end medical imaging equipment, home medical equipment, smart portable medical equipment and other fields will be of great concern. -
艾媒报告 |2019中国按摩椅产业及共享按摩椅市场分析报告
本报告研究涉及企业/品牌/案例:京东,傲胜,荣泰健康,奥佳华,V3 group,云享云,小摩兽,码上按摩,恒林椅业,INGREM英格瑞玛,头等舱,爽蛙,尚铭电器,东方神,荣康,奥佳华,荣泰健康,豪中豪,乐金健康,康忆安,永禾康,本博,乐尔康,南极人,佳仁,茗振,QTQ,志高,乐摩吧,摩摩哒,爽客,码客街,头等舱互联奇拉,久工实业
中国老年人数量增长、亚健康人群超75.0%,具有养生需求的人群利好按摩椅市场的发展。2018年,中国按摩椅相关企业获投资金额2.6亿元,平均每笔按摩椅投资额超过5000万元。具体到两大电商销售渠道,按摩椅在天猫商城的月销售千笔以上的单品均价为3158.9元,京东商城热销前十的单品均价为6529.8元。在按摩市场细分企业中,2018荣泰健康、奥佳华第一大品类均为按摩椅,其营收占比分别为83.0%、42.2%。在按摩概念的广泛渗透下,共享按摩椅开始出现,目前主要应用场景在电影院、景区、地铁站、写字楼等。
The number of elderly people in China has increased, and the number of sub-healthy people has exceeded 75.0%. People who have health needs are in favor of the development of massage chair market. In 2018, China's massage chair-related enterprises received an investment of 260 million yuan, with an average investment of more than 50 million yuan per massage chair. Specifically to the two major e-commerce sales channels, the average price of massage chairs in Tianmao Mall is 3158.9 yuan per month, while the average price of the top ten items in Jingdong Mall is 6529.8 yuan. In the massage market segment enterprises, Rongtai Health and Ogawa's first major category in 2018 are massage chairs, whose revenue accounts for 83.0% and 42.2% respectively. Under the extensive penetration of massage concept, the sharing massage chair began to appear. At present, the main application scenarios are in cinemas, scenic spots, subway stations, office buildings, etc. -
艾媒报告|2019-2021年中国中药材行业发展现状及产业链分析报告
本报告研究涉及企业/品牌/案例:白云山,同仁堂,云南白药,昆明制药,华润三九,天士力,央视财经,牛黄,薏仁,茯苓,黄芪,川芎,片仔癀,中国中药,紫鑫药业,九洲药业,陇神戎发,众生药业,通化金马,江中药业,寿仙谷,新天药业,盘龙药业,佛慈制药,昆药集团,香雪制药,六味地黄丸,人参养荣丸,四神丸,白蚀丸,血脂康胶囊,茵栀黄口服液,一捻金胶囊,乙肝益气解郁颗粒,二十七味定坤丸,十六味冬青丸,参芪消渴胶囊,十香返生丸,华润三九,红日药业,源和药业,太龙药业,中智药业,培力控股,盛实百草,芍花堂,亳药千草,汇群中药
国内经济增长以及居民消费水平的提高都刺激着中药医疗消费需求的增长。iiMedia Research(艾媒咨询)调查显示,有49%的受访用户倾向中医药治疗,与西药基本持平。2018年中国中药材市场规模达1246亿元,同比增长22.40%,在巨大的需求驱动下,中药材种植面积扩大,药材产量将会持续增长。
中药材主要包括上游种植、养殖市场,中游流通市场和下游销售市场三大环节。目前,中药饮片和中成药生产是中药产业的核心,主要包括中药加工,包括中药配方颗粒、中药饮片加工、中成药制造等。中药饮片领域方面,行业销售收入增速分别在2016和2018年触底回升,华润三九、中国中药、红日药业等上市公司表现良好;中药配方颗粒方面,2006-2016年,中国市场销售额占饮片市场销售额比重由1.2%增加至6.0%,中药配方颗粒或将成为中药饮片加工行业应用广泛的产品;中成药方面,随着国家医改政策的推行,中成药消费需求趋于合理,中成药产量开始回落,但仍处于一个比较高的产量水平,云南白药、白云山、同仁堂、紫鑫药业等上市企业表现良好。
Chinese medicinal materials mainly include upstream planting, breeding market, midstream circulation market and downstream sales market three links. At present, the production of Chinese medicine tablets and traditional Chinese medicine is the core of the Chinese medicine industry, including the processing of Traditional Chinese medicine, including Chinese medicine formula particles, Chinese medicine tablet processing, traditional Chinese medicine manufacturing. In the field of Chinese medicine tablets, the growth rate of sales revenue in the industry rebounded in 2016 and 2018, respectively, china Resources 39, Chinese medicine, Red Day Pharmaceuticals and other listed companies performed well; Chinese medicine formula particles may become a widely used product in the Chinese medicine tablet processing industry, Chinese medicine, with the implementation of the national medical reform policy, the consumption demand of traditional Chinese medicine tends to be reasonable, the production of Traditional Chinese medicine began to fall, but still at a relatively high level of production, Yunnan White Medicine, Baiyunshan, Tongrentang, Zixin Pharmaceutical and other listed enterprises performed well. -
艾媒报告|2019-2025全球5G产业发展趋势与商业应用模式研究报告
本报告研究涉及企业/品牌/案例:华为,电信,国脉科技,杰赛科技,恒泰实达,吉大通信,通宇通讯,京信通信,摩比发展(港股),东山精密,盛路通信,飞荣达,摩比发展(港股),东山精密,盛路通信,飞荣达,光迅科技,中际旭创,新易盛,天孚通信,剑桥科技,中兴通讯,诺基亚(美股),爱立信(美股),海格通信,宜通世纪,中富通,超讯通信,中通国脉,吉大通信,纵横通信
全球主要经济体加速推进5G商用落地,目前中国5G产业已形成规划、建设、运营和应用四大产业链环节,产业发展前景广阔,预计2025年中国5G连接数将达4.28亿个,带动直接经济产出达3.3万亿元。iiMedia Research(艾媒咨询)监测发现,2018年中国5G产业链各个环节相关企业营收均超亿元,发展态势良好。调查显示,有73.0%的网民看好5G技术未来发展,智能制造、车辆网、无线医疗是网民关注热点领域。而资本市场也积极关注5G产业生态圈,随着5G融入多项技术的程度加深,未来5G在传统行业的创新应用将成为重要的经济增长点,智慧出行、智慧医疗等下游应用率先成投资热点。
Major global economies have accelerated the promotion of 5G commercial landing. At present, China's 5G industry has formed four major industrial chains: planning, construction, operation and application. The industry has broad prospects for development. It is estimated that the number of 5G links in China will reach 428 million in 2025, and the direct economic output will reach 3.3 trillion yuan. IiMedia Research (Ai Media Consulting) monitoring found that in 2018, China's 5G industry chain in all aspects of the relevant enterprises revenue exceeded 100 million yuan, the development trend is good. According to the survey, 73.0% of the netizens are optimistic about the future development of 5G technology. Intelligent manufacturing, vehicle network and wireless medical treatment are the hotspots of netizens'attention. The capital market also pays close attention to the 5G industrial ecosphere. With the deepening integration of 5G into many technologies, the innovative application of 5G in traditional industries will become an important economic growth point in the future, and downstream applications such as smart travel and smart medical treatment will be the first investment hotspot. -
艾媒报告丨2019中国养老产业发展剖析与发展趋势分析报告
本报告研究涉及企业/品牌/案例包括:祥颐养老、华人照护、颐寿养老、朗高养老、普亲养老、永安林业、双箭股份、尚荣医疗、新华保险、中国平安、鱼跃医疗、海南椰岛、安邦人寿、泰康之家、亲和源、诚和敬、乐成养老、日月星、欧葆庭、椿萱茂
中国养老产业处于高速发展阶段,iiMedia Research(艾媒咨询)数据显示,2018年中国养老产业市场规模将已达6.57万亿元,医养结合成为行业发展新热点,预计2021年医养结合行业市场规模将突破1万亿元。目前,中国养老产业已形成成熟的产业链和六大主要商业模式,但同时也面临着体制性障碍、供需结构失衡、养老服务体系不健全等发展问题。
Driven by policy support, technological development, social changes and market demand, China's pension industry is developing rapidly. According to iiMedia Research, the national pension industry market has reached 6.57 trillion yuan in 2018, and is expected to reach 8.81 trillion yuan in 2021. At present, China's pension industry has formed an industrial chain including resource suppliers such as raw materials and energy, pension suppliers, pension real estate providers and pension service providers, and individual and institutional consumers. The industry is developing well and some pensions enterprise revenue reached 100 million yuan in 2018. Under the vigorous promotion of the Chinese government, the reform of the community pension model, the continuous advancement of wisdom and pension, and the combination of medical care have become hot spots in the industry. It is expected that the market scale of the combination of medical and nursing industry will exceed 1 trillion yuan in 2021. At this stage, China's pension industry, including monthly fee system, property sales, after-sales leaseback, membership system, insurance pension and community pay-as-you-go, has gradually developed and improved. The industry has broad prospects for development, but it also faces institutional Development problems such as obstacles, imbalanced supply and demand structure, and inadequate pension service system. iiMedia Consulting analysts believe that in the future, a new pension service system based on home-based, community-based, institutional supplement, and medical care will be gradually formed, and the development of pension financial market will be more perfect. -
艾媒报告 |2018-2019中国体检行业研究与商业投资决策分析报告
iiMedia Research(艾媒咨询)数据显示,2018年中国体检行业市场规模将超1500亿元。医疗保健支出方面,2017年,中国城镇居民人均医疗保健支出已超1800元,农村居民人均医疗保健支出亦超1000元。随着国民健康管理意识的提高,中国体检人次数逐年增加,2017年已突破5亿人次,未来健康管理服务种类增加或成体检行业发展关键。
According to iiMedia Research data, the market size of China's physical examination industry will exceed 150 billion yuan in 2018. In terms of health care expenditure, in 2017, the per capita health care expenditure of urban residents in China has exceeded 1,800 yuan, and the per capita health care expenditure of rural residents has exceeded 1,000 yuan. With the improvement of national health management awareness, the number of physical examiners in China has increased year by year. In 2017, it has exceeded 500 million person-times. In the future, the increase in the types of health management services may become the key to the development of the physical examination industry.
没找到想要的报告?
扫码添加客服参与预约/定制,第一时间获取行业推荐报告!
智库热榜
艾媒咨询|2024-2025年中国银发经济投资前景分析报告
艾媒咨询|2024-2025年中国烘焙食品行业现状及趋势研究报告
艾媒咨询 | 2023-2024年中国休闲食品产业现状及消费行为数据研究报告
艾媒咨询|2024-2025年全球及中国新能源汽车行业消费趋势监测与案例研究报告
艾媒咨询 | 2023-2024年中国全域旅游产业运行数据及发展趋势研究报告
艾媒咨询 | 2024年中国家用美容仪行业消费者洞察研究报告
艾媒咨询|赵一鸣零食店消费行为洞察及行业趋势报告(2024)
艾媒咨询|2024年中国月饼行业创新发展研究报告
艾媒咨询 | 2024年中国数字中台市场研究报告
艾媒咨询|2023-2024年全球及中国跨境电商运营数据及典型企业分析研究报告
艾媒咨询|2024年中国家清产品消费趋势洞察报告